Geode Capital Management, LLC Kala Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.3 - $1.31 $152,127 - $664,287	-507,090 Reduced 53.11%	447,683 $134,000
Q1 2022 May 13, 2022	BUY	$0.61 - $1.84 $85,423 - $257,671	140,039 Added 17.19%	954,773 $1.32 Million
Q4 2021 Feb 11, 2022	SELL	$1.16 - $2.74 $137,469 - $324,711	-118,508 Reduced 12.7%	814,734 $985,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $471,453 - $977,095	179,944 Added 23.89%	933,242 $2.45 Million
Q2 2021 Aug 13, 2021	BUY	$5.06 - $8.15 $358,293 - $577,093	70,809 Added 10.38%	753,298 $3.99 Million

Q1 2021 May 12, 2021	BUY	$6.24 - $9.58 $503,948 - $773,690	80,761 Added 13.42%	682,489 $4.6 Million
Q4 2020 Feb 12, 2021	BUY	$6.28 - $8.79 $117,253 - $164,118	18,671 Added 3.2%	601,728 $4.08 Million
Q3 2020 Nov 13, 2020	SELL	$7.5 - $11.11 $349,560 - $517,814	-46,608 Reduced 7.4%	583,057 $4.37 Million
Q2 2020 Aug 13, 2020	BUY	$8.33 - $13.79 $2.37 Million - $3.93 Million	284,934 Added 82.65%	629,665 $6.62 Million
Q1 2020 May 14, 2020	BUY	$3.83 - $8.79 $28,031 - $64,334	7,319 Added 2.17%	344,731 $3.03 Million
Q4 2019 Feb 13, 2020	BUY	$3.36 - $4.81 $105,759 - $151,399	31,476 Added 10.29%	337,412 $1.25 Million
Q3 2019 Nov 12, 2019	BUY	$3.57 - $6.58 $3,748 - $6,909	1,050 Added 0.34%	305,936 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$4.93 - $8.8 $235,654 - $420,640	47,800 Added 18.59%	304,886 $1.95 Million
Q1 2019 May 14, 2019	BUY	$5.19 - $8.97 $296,613 - $512,644	57,151 Added 28.58%	257,086 $2.13 Million
Q4 2018 Feb 13, 2019	BUY	$4.29 - $9.94 $379,596 - $879,530	88,484 Added 79.39%	199,935 $977,000
Q3 2018 Nov 13, 2018	BUY	$9.54 - $13.87 $182,986 - $266,040	19,181 Added 20.79%	111,451 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $104,298 - $137,156	7,842 Added 9.29%	92,270 $1.27 Million
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $189,306 - $293,070	15,441 Added 22.38%	84,428 $1.34 Million
Q4 2017 Feb 13, 2018	BUY	$13.68 - $23.17 $45,116 - $76,414	3,298 Added 5.02%	68,987 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $1.3 Million - $1.74 Million	65,689	65,689 $1.5 Million

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$7
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.4M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account